Navigation Links
Once-Weekly Diabetes Drug Boosts Blood Sugar Control
Date:9/7/2008

But Byetta has also been linked recently to patient deaths

SUNDAY, Sept. 7 (HealthDay News) -- A new once-a-week formulation of the injectable diabetes drug Byetta controls blood sugar even better than the older twice-a-day formulation, researchers report.

"Besides obvious improved ease of use, [the new formulation] provided the remarkable advantage of both improved efficacy on glucose control and good gastrointestinal tolerability," said Dr. Andre Scheen of the University of Liege in Belgium, in a commentary accompanying the study's publication online Sunday in The Lancet.

The study, led by Dr. Daniel Drucker of Mount Sinai Hospital and the University of Toronto, Canada, is also slated for presentation Sunday at The European Association for the Study of Diabetes meeting, in Rome.

The findings, while encouraging, come on the heels of less-heartening news about Byetta (exenatide). On Aug. 26, the drug's makers, Eli Lilly and Amylin Pharmaceuticals Inc., reported the pancreatitis-linked deaths of four people who'd been taking the medication. That news came a week after the U.S. Food and Drug Administration said that two Byetta users had died of acute pancreatitis, a condition that can cause nausea, vomiting and abdominal pain.

While Byetta use has not been confirmed as a causative factor in these deaths, the FDA has noted an association between Byetta use and pancreatitis, and on Aug. 18 announced it was working on stronger labeling for the injected drug, which has been used by more than 700,000 people since being approved in June 2005.

The new study involved 259 patients with type 2 diabetes who received 30-week courses of either 2 milligrams of long-acting release Byetta given once weekly, or 10 microgram doses given twice a day. Researchers monitored blood sugar control via levels of hemoglobin A1C in the blood (HbA1C), which averaged 8.3 percent at the start of the study.

According to the researchers, HbA1C levels fell to a mean of 6.4 percent among the Byetta once-weekly group, versus 6.8 percent for those on the twice-daily regimen. More patients on the weekly dose achieved a target Hb1AC level of 7 percent (77 percent) than those on the twice-a-day regimen (61 percent).

Overall, the once-a-week formulation provided patients with better blood sugar control than the twice-daily regimen, the authors wrote, "with no increased risk of hypoglycaemia and similar reductions in body weight."

The findings echo those from a similar study reported June 10 at the American Diabetes Association meeting in San Francisco. In their year-long study of 295 type 2 diabetics, researchers at the University of North Carolina School of Medicine, Chapel Hill, found that 74 percent of all participants achieved an HbAIC level of 7 percent or less -- regardless of whether they received Byetta once a week or twice daily.

More information

To learn more, visit the FDA.



-- E.J. Mundell



SOURCE: The Lancet, news release, Sept. 7, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
2. Adverse housing conditions contribute to diabetes risk
3. RAND finds cases of undiagnosed diabetes drop sharply
4. UCLA researchers identify markers that may predict diabetes in still-healthy people
5. Diabetes appears to increase risk of death for patients with acute coronary syndromes
6. Discovery of sugar sensor in intestine could benefit diabetes
7. Despite overeating, morbidly obese mice gain protection against diabetes
8. Heart Attack Boosts Diabetes Risk
9. Obesity Doesnt Always Equal Diabetes
10. Sugary Sodas High in Diabetes-Linked Compound
11. Treating diabetes during pregnancy can break link to childhood obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
Breaking Medicine Technology: